Xiangzhong Xue

2PUBLICATIONS
2CO-AUTHORS
Molecular targetsNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 29, 2024
Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database.

Xiangzhong Xue, Jingjing Qian

|Mar 09, 2023
Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States.

Xiangzhong Xue, Bang Truong, Jingjing Qian

Pageof 1

Frequent Collaborators

2 joint publications

Jingjing Qian

1 joint publications

Bang Truong